Trials / Recruiting
RecruitingNCT07016685
Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery
Prognostic Factors for 90-day Mortality in Patients Undergoing Veno-venous Extracorporeal Membrane Oxygenation for Emergency Thoracic Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 380 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).
Conditions
- VV-ECMO
- Thoracic Surgery
- Emergency Surgery
- ARDS
- Retrospective Cohort
- Propensity Score Matching
- Mortality
- ECMO Outcomes
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-11-01
- Completion
- 2026-04-01
- First posted
- 2025-06-12
- Last updated
- 2025-06-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07016685. Inclusion in this directory is not an endorsement.